Primary Infection Resource Consortium (PIRC)
Primary Infection Resource Consortium (PIRC)
批准号:
9348986
负责人:
SUSAN JANET LITTLE
金额:
$331.19万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-20 至 2022-03-31
关键词:
AIDS clinical trial groupAIDS preventionAcquired Immunodeficiency SyndromeAcuteAddressAdoptedAreaBasic ScienceBehavioralBiologicalBiological AssayBiomedical ResearchCaliforniaCaringChronicClinicClinicalClinical ResearchCollaborationsCommunitiesCommunity NetworksCommunity OutreachDataDetectionEnrollmentEnsureFrequenciesFundingFutureHIVHIV InfectionsHIV diagnosisHealth ResourcesHealth Services AdministrationHuman immunodeficiency virus testIncidenceIndividualInfectionInterruptionLocationManuscriptsMeasuresMedicalMethodsMonitorMonoclonal Antibody R24Newly DiagnosedNucleic Acid Amplification TestsOutcomeParticipantPeer ReviewPerformancePersonsPopulationPreventionPrimary InfectionProcessRNARecruitment ActivityRegistriesReportingResearchResearch InfrastructureResearch PersonnelResistanceResource SharingResourcesSamplingSan FranciscoSerologicalServicesSiteSpecimenStagingSystemTechnologyTestingTimeTissuesTranslational ResearchTransportationTravelUnited StatesUnited States National Institutes of HealthUniversitiesUpdateVisitantiretroviral therapybiobankcohortcollaboratorycostdata managementfollow-uphigh riskimprovedindexingneuroAIDSneurobehavioralpoint of carepre-exposure prophylaxisprevention serviceprogramsresponsescreeningsocioeconomicstherapy adherencetransmission processvaccine trialvirologyvoucher
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
HIV incidence is still increasing in the U.S. despite intense efforts to: (i) diagnose HIV infection as early as
possible, (ii) engage newly diagnosed individuals into care and (iii) start antiretroviral therapy (ART) for all
infected persons. The San Diego Primary Infection Resource Consortium (PIRC) has been tackling the
evolving challenges around these issues for twenty years. The PIRC is the largest, most intensively studied
and well-characterized cohort of acute and early HIV infected (AEH) individuals in the United States. It has
provided essential support to over 325 peer-reviewed original research manuscripts, spanning a wide range of
fields, and including many NIH priority areas for HIV research, including: HIV incidence, strategies to improve
HIV testing and entry into prevention services, etc. This application represents a renewal of our PIRC R24
(AI106039) with the proposal to continue this highly productive program, supporting the infrastructure needed
to identify, characterize, and share clinical and biological data with scientific colleagues whose research
objectives rely upon access to these biological samples and data. The proposed R24 renewal application
includes a new collaboration between PIRC and the Center for AIDS Research (CFAR) Network of Integrated
Clinical Systems (CNICS) to develop an expanded and synergistic resource to serve biomedical research in
the area of AEH. Overall, the PIRC supports: 1) an HIV screening program to detect and stage acute, recent
and chronic infection, 2) partner services to identify sexual contacts of newly HIV diagnosed AEH participants
(i.e., “index” subjects), 3) immediate provision of ART, 4) prompt linkage to care, 5) monitoring of ART
adherence and continued engagement in care, 6) methods to estimate putative HIV transmission and 6) an
AEH biorepository. This entire biorepository and data associated with these well characterized participants are
available to qualified investigators, requiring only internal review and approval of a concept proposal. The
proposed R24 renewal application will address the following Specific Aims: Aim 1. Community HIV Testing
and Acute and Early HIV (AEH) Infection Staging. We propose to identify 120 newly HIV diagnosed persons
per year at the University of California San Diego: 47 AEH infected and 73 chronically infected participants.
Aim 2. Improve Continuum of HIV Prevention and Treatment. We will evaluate temporal changes in the
HIV treatment cascade in response to coordinated efforts to support immediate ART in newly HIV diagnosed
PIRC participants. Subjects identified during AEH will be followed for up to 5 years, while chronically infected
subjects will be followed in clinic for up to 90 days. Aim 3. Shared Resources. We will leverage AEH
specimen and participant resources to support additional NIH research collaborations related to primary HIV
infection. Co-enrollment of AEH participants in CNICS will leverage the clinical monitoring of validated
outcomes and longitudinal resistance data provided by CNICS. The PIRC will serve as a resource to support
high quality basic, clinical and translational research related to AEH.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Miami Dade County ASsessment of Phylogenetics to Improve Resource Equity: MD ASPIRE
-
批准号:10653972
-
项目类别:
-
资助金额:$96.07万
-
财政年份:2022
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Core-001 - COPE Core B
-
批准号:10602740
-
项目类别:
-
资助金额:$46.87万
-
财政年份:2022
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Miami Dade County ASsessment of Phylogenetics to Improve Resource Equity: MD ASPIRE
-
批准号:10460007
-
项目类别:
-
资助金额:$98.69万
-
财政年份:2022
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Core-001 - COPE Core B
-
批准号:10459873
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2022
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
-
批准号:10212958
-
项目类别:
-
资助金额:$73.77万
-
财政年份:2020
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
-
批准号:10405074
-
项目类别:
-
资助金额:$79.23万
-
财政年份:2020
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
-
批准号:10640251
-
项目类别:
-
资助金额:$77.35万
-
财政年份:2020
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
-
批准号:10082384
-
项目类别:
-
资助金额:$81.1万
-
财政年份:2020
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Core B: Clinical and Anatomic Pathology Core
-
批准号:10223141
-
项目类别:
-
资助金额:$40.57万
-
财政年份:2017
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Efficacy of ART to Interrupt HIV Transmission Networks
-
批准号:8658916
-
项目类别:
-
资助金额:$71.26万
-
财政年份:2014
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Efficacy of ART to Interrupt HIV Transmission Networks
-
批准号:8848139
-
项目类别:
-
资助金额:$64.79万
-
财政年份:2014
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (PIRC)
-
批准号:9765135
-
项目类别:
-
资助金额:$339.42万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (Pirc)
-
批准号:9108834
-
项目类别:
-
资助金额:$144.35万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (Pirc)
-
批准号:9237672
-
项目类别:
-
资助金额:$17.83万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (PIRC)
-
批准号:10221460
-
项目类别:
-
资助金额:$338.03万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (Pirc)
-
批准号:8723059
-
项目类别:
-
资助金额:$160.12万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Primary Infection Resource Consortium (Pirc)
-
批准号:8510795
-
项目类别:
-
资助金额:$143.09万
-
财政年份:2013
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Determinants of HIV Transmission
-
批准号:8063769
-
项目类别:
-
资助金额:$211.39万
-
财政年份:2010
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Determinants of HIV Transmission
-
批准号:7917094
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2009
-
负责人:SUSAN JANET LITTLE
-
依托单位:
Determinants of HIV Transmission
-
批准号:7799178
-
项目类别:
-
资助金额:$438.32万
-
财政年份:2008
-
负责人:SUSAN JANET LITTLE
-
依托单位:
海外基金